Sensile Medical is acquired by Gerresheimer AG

Friday, July 13, 2018

Gerresheimer acquires Swiss technology company Sensile Medical AG, fundamentally expanding its business model. Sensile Medical offers valuable synergies and improved access to potential customers. The acquisition will enable Gerresheimer to offer drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.

The acquisition will enable Sensile Medical to operate in an internationally operating, global, pharmaceutical and healthcare-focused global enterprise.

Thanks to the broad product range of Gerresheimer, useful starting points can already be found in the development of primary drug products at an early stage of drug and therapy development. Furthermore, the exploitation of synergies for the production of products, especially with the business unit Medical Plastic Systems, is trend-setting.

It is planned that Sensile Medical will become the development area for the entire Gerresheimer Group in the field of value added devices.

Andreas Schütte, CEO Gerresheimer AG, Plastics & Devices "We are accelerating our growth and setting important course for the next few years. Sensile Medical fits in perfectly with us as it develops innovative drug delivery products and platforms, including networking. "

"The transaction is a milestone in the implementation of our growth strategy for Sensile Medical, and we are confident that with Gerresheimer we have found the ideal partner to position ourselves optimally for the future and look forward to working with Gerresheimer," explains Derek Brandt , CEO of Sensile Medical.